The FDA’s Review Of Abortion Drugs Is Long Overdue
Andrew Harnik/Getty Images

Opinion

The FDA’s Review Of Abortion Drugs Is Long Overdue

The agency's approach to mifepristone was political from the start.

J. Marc Wheat

Last month marked 25 years since the Food and Drug Administration approved the abortion drug mifepristone, then called RU-486, for use in the United States.

On September 19, Health and Human Services Secretary Robert F. Kennedy, Jr., and the FDA Commissioner Marty Makary, sent a letter to 22 pro-life state attorneys general informing them that the agencies will perform a review of the drug’s safety.

Got a tip worth investigating?

Your information could be the missing piece to an important story. Submit your tip today and make a difference.

Submit Tip